Evidence map›Paper›PMID 38505564›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2024

Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation.

Vinai Bhagirath, Tanya Kovalova, Jia Wang, Lizhen Xu, Shrikant I Bangdiwala, Martin O'Donnell, Ashkan Shoamanesh, Jackie Bosch, Rosa Coppolecchia, Tatsiana Vaitsiakhovich and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Molecular-gated MRIMaterials today. Bio · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Vinai BhagirathPopulation Health Research Institute, Hamilton, Ontario, Canada.
Tanya KovalovaPopulation Health Research Institute, Hamilton, Ontario, Canada.
Jia WangPopulation Health Research Institute, Hamilton, Ontario, Canada.
Lizhen XuPopulation Health Research Institute, Hamilton, Ontario, Canada.
Shrikant I BangdiwalaPopulation Health Research Institute, Hamilton, Ontario, Canada.
Martin O'DonnellPopulation Health Research Institute, Hamilton, Ontario, Canada.
Ashkan ShoamaneshPopulation Health Research Institute, Hamilton, Ontario, Canada.
Jackie BoschMcMaster University, Hamilton, Ontario, Canada.
Rosa CoppolecchiaBayer US LLC, St. Louis, Missouri, United States.
Tatsiana VaitsiakhovichBayer AG, Berlin, Germany.
Frank KleinjungBayer AG, Berlin, Germany.
Hardi MundlBayer AG, Wuppertal, Germany.
John EikelboomPopulation Health Research Institute, Hamilton, Ontario, Canada.
Population Health Research Institute · CABayer (Germany) · DEMcMaster University · CABayer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antithromboticatrial fibrillationbleedingESUS, CAD, PADrisk prediction

Identifiers

PMID38505564
PMCPMC10948265
OpenAlexW4391424464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.